Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 5/20 | 0.50 |
| ▸ | RAB9A | P51151 | 3/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | ERN1 | O75460 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 3/20 | 0.46 |
| ▸ | GAA | P10253 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3724251 | 0.85 | CSNK2A1 (0.60) | MAPTRAB9AL3MBTL1ATMSMN1; SMN2 | |
| SCHEMBL3172287 | 0.84 | HSD17B10 (0.46) | RORCMAPTRAB9ALMNASMN1; SMN2 | |
| SCHEMBL10709145 | 0.83 | HSD17B10 (0.50) | MAPTRAB9AL3MBTL1HSD17B10POLB | |
| SCHEMBL19646170 | 0.81 | ALDH1A1 (0.44) | RORCMAPTRAB9AL3MBTL1ATM | |
| SCHEMBL3026188 | 0.81 | CALM1 (0.51) | MAPTLMNAHSD17B10POLBGAA | |
| SCHEMBL3721034 | 0.81 | HSD17B10 (0.43) | MAPTHSD17B10TDP1TSHRCYP1A2 | |
| SCHEMBL9698942 | 0.80 | THRA (0.54) | RAB9AL3MBTL1ATMSMN1; SMN2KMT2A | |
| SCHEMBL9734720 | 0.80 | THRA (0.54) | RAB9AL3MBTL1ATMSMN1; SMN2KMT2A | |
| SCHEMBL9698883 | 0.80 | THRA (0.54) | RAB9AL3MBTL1ATMSMN1; SMN2KMT2A | |
| SCHEMBL9647635 | 0.80 | THRA (0.54) | RAB9AL3MBTL1ATMSMN1; SMN2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5151458-A | Molding materials for liquid crystal resins | BAYER AKTIENGESELLSCHAFT (DE) | 1992-09-29 | — | — | US | claimed |
| US-5143956-A | Blends with low molecular weight liquid crystals | BAYER AKTIENGESELLSCHAFT (DE) | 1992-09-01 | — | — | US | claimed |
| CN-122036680-A | Anti-fibrotic pyridones | 英特穆恩公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-114950548-A | Application of eutectic ionic liquid in preparation of phenol or derivatives thereof by dealkylation of phenol alkyl ether compounds | 宁夏中星显示材料有限公司 | 2022-08-30 | — | — | CN | disclosed |
| CN-110452216-B | Anti-fibrotic pyridinones | 英特穆恩公司 | 2022-08-26 | — | — | CN | disclosed |
| US-10898474-B2 | Anti-fibrotic pyridinones | INTERMUNE, INC. (US) | 2021-01-26 | — | — | US | disclosed |
| EP-2903991-B1 | ANTI-FIBROTIC PYRIDINONES | INTERMUNE INC (US) | 2020-09-16 | — | — | EP | disclosed |
| US-10544161-B2 | Anti-fibrotic pyridinones | INTERMUNE, INC. (US) | 2020-01-28 | — | — | US | disclosed |
| US-20190321343-A1 | Anti-Fibrotic Pyridinones | GENENTECH, INC. | 2019-10-24 | — | — | US | disclosed |
| US-10376497-B2 | Anti-fibrotic pyridinones | INTERMUNE, INC. (US) | 2019-08-13 | — | — | US | disclosed |
| US-20190144467-A1 | ANTI-FIBROTIC PYRIDINONES | GENENTECH, INC. | 2019-05-16 | — | — | US | disclosed |
| US-5030703-A | Polyesters, polycarbonateesters, polylactones | BAYER AKTIENGESELLSCHAFT (DE) | 1991-07-09 | — | — | US | disclosed |
| EP-0406745-A1 | Antibiotic GE 2270 factors A1, A2, A3 and H | GRUPPO LEPETIT S.p.A. (IT) | 1991-01-09 | — | — | EP | disclosed |
| US-4960539-A | Use of fluoromethylphenols as solvents for LC-polymers, and new fluoromethylphenols | BAYER AKTIENGESELLSCHAFT (DE) | 1990-10-02 | — | — | US | disclosed |
| US-4945130-A | Molding compositions of polycarbonate, thermotropic polymer, graft polymer and fluorinated polyolefin | BAYER AKTIENGESELLSCHAFT (DE) | 1990-07-31 | — | — | US | disclosed |
| US-4886869-A | OPTIONALLY SUBSTITUTED WITH-3-HYDROXY BENZOIC ACID; RIGIDITY, IMPACT STRENGTH AND ELONGATION | BAYER AKTIENGESELLSCHAFT (DE) | 1989-12-12 | — | — | US | disclosed |
| US-4599395-A | Thermotropic, aromatic polyesters having good mechanical strength, containing sulfonic acid groups or metal sulfonate groups a process for the production thereof | BAYER AKTIENGESELLSCHAFT (DE) | 1986-07-08 | — | — | US | disclosed |
| EP-0024499-B1 | BIAXIALLY ORIENTED WHOLLY AROMATIC POLYESTER FILM AND PROCESS FOR PRODUCING SAME | TEIJIN LIMITED (JP) | 1984-03-07 | — | — | EP | disclosed |
| US-4333907-A | Biaxially oriented wholly aromatic polyester film | TEITIN LIMITED (JP) | 1982-06-08 | — | — | US | disclosed |
| EP-0024499-A1 | Biaxially oriented wholly aromatic polyester film and process for producing same | TEIJIN LIMITED (JP) | 1981-03-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10544161-B2 | Anti-fibrotic pyridinones | MMP1, COL1A1, COL2A1 | RORC 1349/4885MAPT 4377/4885RAB9A 2353/4885 |
| US-20190321343-A1 | Anti-Fibrotic Pyridinones | MMP1, COL1A1, COL2A1 | RORC 1349/4885MAPT 4377/4885RAB9A 2353/4885 |
| US-10376497-B2 | Anti-fibrotic pyridinones | MMP1, COL1A1, COL2A1 | RORC 1349/4885MAPT 4377/4885RAB9A 2353/4885 |
| US-10898474-B2 | Anti-fibrotic pyridinones | MMP1, COL1A1, COL2A1 | RORC 1349/4885MAPT 4377/4885RAB9A 2353/4885 |
| US-20190144467-A1 | ANTI-FIBROTIC PYRIDINONES | MMP1, COL1A1, COL2A1 | RORC 1349/4885MAPT 4377/4885RAB9A 2353/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.